TASMAN PHARMA
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 17 Nov 2026, and its filing window is open now).
Record
- Serial number
- 87569014
- Registration number
- 6200747
- Mark type
- Word mark
- Filed
- 15 Aug 2017
- Published for opposition
- 14 Aug 2018
- Registered
- 17 Nov 2020
- Next maintenance filing
- §8 declaration of use, due by 17 Nov 2026 (grace period to 17 May 2027)
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders
Owner
- Douglas Pharmaceuticals Limited, Auckland, NZ
- Douglas Pharmaceuticals Limited, Auckland, NZ
- Douglas Pharmaceuticals Limited, Auckland, NZ
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Oct 2020 — USE AMENDMENT FILED
- 06 Oct 2020 — TEAS STATEMENT OF USE RECEIVED
- 08 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Apr 2020 — SOU EXTENSION 3 GRANTED
- 06 Apr 2020 — SOU EXTENSION 3 FILED
- 06 Apr 2020 — SOU TEAS EXTENSION RECEIVED
- 16 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2019 — SOU EXTENSION 2 GRANTED
- 09 Oct 2019 — SOU EXTENSION 2 FILED
- 15 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL